Table 1.
Model | Effect | Components | Reference |
---|---|---|---|
Clinical study | Potentially reduced abdominal pain and modification of stool consistency for patients with irritable bowel syndrome | Non-viable probiotic lysate of Escherichia coli DSM 17252 and Enterococcus faecalis DSM 16440 | [15] |
In vitro | Inhibition of lipid accumulation during adipocyte differentiation | Cell lysate of Lactobacillus plantarum K8 | [16] |
In vitro | Antibacterial and antioxidant activity | The cell-free supernatant from L. plantarum RG11, RG14, RI11, RS5, TL1, and UL4 | [17] |
In vitro | Antibacterial and antibiofilm activity | The cell-free supernatant from L. sakei EIR/CM-1 | [18] |
In vitro | Antimicrobial activity | Metabolic products of L. acidophilus LA5, L. casei 431, and L. salivarius | [19] |
In vitro | Increased interleukin IL10 concentration and expression CD103 and CD1d Downregulated expression of NFκB1, RELB, and TNF genes Influenced retinoic acid—driven mucosal-like dendritic cells |
The cell-free supernatant from L. reuteri DSM 17938 | [20] |
In vitro and animal model mice | Immunomodulatory effect | Milk fermentation product using Brevibacterium breve C50 and Streptococcus thermophiles 065 | [21] |
Animal—mice | Improving the parameters associated with intestinal mucositis induced by chemotherapy | Heat inactivated cells of L. rhamnosus | [22] |
Animal—rat | Preventing periodontitis by reducing alveolar bone loss and ameliorating the bone microarchitecture parameters |
Heat inactivated cells of L. reuteri | [23] |
Animal—broiler chickens | Immunomodulatory effect on jejunal tissue Decreased Clostridium perfringens colony counts, decreased lesions scores, and mortality |
Fermented product produced from a consortium containing Pediococcus acidilactici, L. reuter, Enterococcus faecium, and L. acidophilus | [24] |
Animal—suckling rat | Protection against rotavirus infection | Cell fragments and metabolites of probiotic microorganisms and prebiotics | [25] |
Animal—post-weaning lambs | Immunomodulatory effect (increase of IL-6, decrease of IL1 and TNF) Pathogenic bacteria inhibition |
The cell-free supernatant from L. plantarum RG14 | [26] |
Animal—broiler chickens | Immunomodulatory effect Reduce cell number of Enterobacteria and E. coli |
The cell-free supernatant from L. plantarum RG14 probiotic microorganisms and inulin | [27,28] |
Animal—broiler chickens | Improving growth performance Reduced number of Enterobacteriaceae Increase expression of hepatic IGF-1 and GHR mRNA and plasma immunoglobulins (IgG and IgM) |
The cell-free supernatant from L. plantarum RI11, L. plantarum RS5 and L. plantarum UL4 | [29,30] |
Animal—neonatale rat | Promoting mucin secretion and the epithelial tight junction protein expression | Components of the cell-free supernatant from L. rhamnosus GG | [31] |
Animal—rat | Increase the global bone mineral density | Bacterial lysate and supernatant from L. acidophilus, L. casei, L. reuteri, Bifidobacterium longum, and Bacillus coagulans | [32] |